^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

Single-Cell Mass Cytometry Identifies Mechanisms of Resistance to Immunotherapy in AML

Published date:
11/06/2019
Excerpt:
...we did observe high PD-L2 protein expression in AML cells resistant (the 7 with progressive disease) to HMA/PD-L1 inhibition...
Secondary therapy:
azacitidine
DOI:
10.1182/blood-2019-128601